Expert Interview
A third look discussing the clinical landscape of Thyroid Eye Disease (TED) with an updated look at Tepezza. Also reviewing the potential of Viridian Therapeutics VRDN-001, an anti-IGF-1R antibody for patients with active TED.
Ticker(s): VRDN, HZNPInstitution: Roper St. Francis Physician Partners Endocrinology
- Board certified in Endocrinology
- practices the full range of endocrinology with special interests in diabetes, thyroid issues and calcium disorders
- Treats 250 patients with Hypogonadism and is very familiar with TLANDO
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
